Overview
Varex Q4 revenue grows 11% yr/yr, beating analyst expectations
Non-GAAP EPS for Q4 rises to $0.37 from $0.19 last year
Company's revenue growth driven by Medical and Industrial segments
Outlook
Company expects Q1FY26 revenue between $200 mln and $215 mln
Company anticipates Q1FY26 non-GAAP EPS between $0.05 and $0.25
Result Drivers
MEDICAL SEGMENT - Global CT tube sales drove a 5% increase in Medical segment revenue
INDUSTRIAL SEGMENT - Sustained momentum in cargo systems business led to 25% growth in Industrial segment
GROWTH INITIATIVES - Co advanced photon counting technology for CT and launched radiographic detector from new facility in India
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue | Beat | $229 mln | $219.26 mln (5 Analysts) |
Q4 Net Income | $12.20 mln | ||
Q4 Gross Margin | 34.00% | ||
Q4 Adjusted Operating Margin | 10.00% | ||
Q4 Operating Income | $19.60 mln | ||
Q4 Pretax Profit | $14.10 mln |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Varex Imaging Corp is $16.00, about 28.6% above its November 17 closing price of $11.43
The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 10 three months ago
Press Release: ID:nBw1lcwrWa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)